Lactic acid is a potential virulence factor for group B Streptococcus

Microbial Pathogenesis

Volumn 46, Issue 1, 2009, Pages 43-52

  Kling, David E ^a   Cavicchio, Amanda J ^a   Sollinger, Christina A ^a   Madoff, Lawrence C ^b   Schnitzer, Jay J ^a   Kinane, Thomas B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Acidemia; Acidosis; Fetal; infection; Invasive; Lung; Neonate; Pathogen; pH; Rat; Respiratory; Streptococcus agalactiae; Virulence

Indexed keywords

LACTIC ACID; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CELL DAMAGE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBIAL DEGRADATION; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS AGALACTIAE; TISSUE INJURY;

ANIMALS; CELL LINE; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FETUS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LUNG; ORGAN CULTURE TECHNIQUES; RATS; STREPTOCOCCUS AGALACTIAE; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; POSIBACTERIA; RATTUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 57949102991     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2008.10.009     Document Type: Article

References (50)

1. Baker C.J., and Edwards M.S. Group B streptococcal conjugate vaccines. Arch Dis Child 88 (2003) 375-378
2. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4 (2006) 932-942
3. Doran K.S., and Nizet V. Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol 54 (2004) 23-31
4. Bolduc G.R., Baron M.J., Gravekamp C., Lachenauer C.S., and Madoff L.C. The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell Microbiol 4 (2002) 751-758
5. Baron M.J., Bolduc G.R., Goldberg M.B., Auperin T.C., and Madoff L.C. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem 279 (2004) 24714-24723
6. Baron M.J., Filman D.J., Prophete G.A., Hogle J.M., and Madoff L.C. Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells. J Biol Chem 282 (2007) 10526-10536
7. Bolduc G.R., and Madoff L.C. The group B streptococcal alpha C protein binds alpha1beta1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells. Microbiology 153 (2007) 4039-4049
8. Stalhammar-Carlemalm M., Areschoug T., Larsson C., and Lindahl G. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 33 (1999) 208-219
9. Schubert A., Zakikhany K., Schreiner M., Frank R., Spellerberg B., Eikmanns B.J., et al. A fibrinogen receptor from group B Streptococcus interacts with fibrinogen by repetitive units with novel ligand binding sites. Mol Microbiol 46 (2002) 557-569
10. Bohnsack J.F., Widjaja K., Ghazizadeh S., Rubens C.E., Hillyard D.R., Parker C.J., et al. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis 175 (1997) 847-855
11. Gutekunst H., Eikmanns B.J., and Reinscheid D.J. The novel fibrinogen-binding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect Immun 72 (2004) 3495-3504
12. Chaffin D.O., Mentele L.M., and Rubens C.E. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol 187 (2005) 4615-4626
13. Li J., Kasper D.L., Ausubel F.M., Rosner B., and Michel J.L. Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus. Proc Natl Acad Sci USA 94 (1997) 13251-13256
14. Liu G.Y., Doran K.S., Lawrence T., Turkson N., Puliti M., Tissi L., et al. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci USA 101 (2004) 14491-14496
15. Cieslewicz M.J., Kasper D.L., Wang Y., and Wessels M.R. Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem 276 (2001) 139-146
16. Ramaswamy S.V., Ferrieri P., Madoff L.C., Flores A.E., Kumar N., Tettelin H., et al. Identification of novel cps locus polymorphisms in nontypable group B Streptococcus. J Med Microbiol 55 (2006) 775-783
17. van der Mee-Marquet N., Fourny L., Arnault L., Domelier A.S., Salloum M., Lartigue M.F., et al. Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin and genital body sites. J Clin Microbiol 46 (2008) 2906-2911
18. Lindahl G., Stalhammar-Carlemalm M., and Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18 (2005) 102-127
19. Lachenauer C.S., Creti R., Michel J.L., and Madoff L.C. Mosaicism in the alpha-like protein genes of group B streptococci. Proc Natl Acad Sci USA 97 (2000) 9630-9635
20. Mickelson M.N. Aerobic metabolism of Streptococcus agalactiae. J Bacteriol 94 (1967) 184-191
21. Johnson C.P., Gross S.M., and Hillman J.D. Cariogenic potential in vitro in man and in vivo in the rat of lactate dehydrogenase mutants of Streptococcus mutans. Arch Oral Biol 25 (1980) 707-713
22. Hillman J.D. Genetically modified Streptococcus mutans for the prevention of dental caries. Antonie Van Leeuwenhoek 82 (2002) 361-366
23. Milligan T.W., Doran T.I., Straus D.C., and Mattingly S.J. Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol 7 (1978) 28-33
24. Kling D.E., Gravekamp C., Madoff L.C., and Michel J.L. Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus. Infect Immun 65 (1997) 1462-1467
25. Tarmy E.M., and Kaplan N.O. Chemical characterization of d-lactate dehydrogenase from Escherichia coli B. J Biol Chem 243 (1968) 2579-2586
26. Mat-Jan F., Alam K.Y., and Clark D.P. Mutants of Escherichia coli deficient in the fermentative lactate dehydrogenase. J Bacteriol 171 (1989) 342-348
27. Mickelson M.N. Glucose transport in Streptococcus agalactiae and its inhibition by lactoperoxidase-thiocyanate-hydrogen peroxide. J Bacteriol 132 (1977) 541-548
28. Mickelson M.N. Glucose degradation, molar growth yields, and evidence for oxidative phosphorylation in Streptococcus agalactiae. J Bacteriol 109 (1972) 96-105
29. Yamamoto Y., Poyart C., Trieu-Cuot P., Lamberet G., Gruss A., and Gaudu P. Respiration metabolism of Group B Streptococcus is activated by environmental haem and quinone and contributes to virulence. Mol Microbiol 56 (2005) 525-534
30. Russell G., and McKay E. Blood glucose concentration in the perinatal period. Arch Dis Child 41 (1966) 496-502
31. Shelley H.J. Carbohydrate reserves in the newborn infant. Br Med J 1 (1964) 273-275
32. Kasper D.L. Designer vaccines to prevent infections due to group B Streptococcus. Proc Assoc Am Physicians 107 (1995) 369-373
33. Rooney S.A. Lung surfactant. Environ Health Perspect 55 (1984) 205-226
34. Bourbon J.R., Rieutort M., Engle M.J., and Farrell P.M. Utilization of glycogen for phospholipid synthesis in fetal rat lung. Biochim Biophys Acta 712 (1982) 382-389
35. Gewolb I.H., Barrett C., Wilson C.M., and Warshaw J.B. Delay in pulmonary glycogen degradation in fetuses of streptozotocin diabetic rats. Pediatr Res 16 (1982) 869-873
36. Boskey E.R., Cone R.A., Whaley K.J., and Moench T.R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16 (2001) 1809-1813
37. Boskey E.R., Telsch K.M., Whaley K.J., Moench T.R., and Cone R.A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 67 (1999) 5170-5175
38. Gorodeski G.I., Hopfer U., Liu C.C., and Margles E. Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells. Endocrinology 146 (2005) 816-824
39. Hillman J.D., Brooks T.A., Michalek S.M., Harmon C.C., Snoep J.L., and van Der Weijden C.C. Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries. Infect Immun 68 (2000) 543-549
40. Tamura G.S., Kuypers J.M., Smith S., Raff H., and Rubens C.E. Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun 62 (1994) 2450-2458
41. Hauth J.C., Macpherson C., Carey J.C., Klebanoff M.A., Hillier S.L., Ernest J.M., et al. Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 188 (2003) 831-835
42. Kling D.E., Madoff L.C., and Michel J.L. Subcellular fractionation of group B Streptococcus. Biotechniques 27 (1999) 24-26 28
43. Kling D.E. Peptide heterogeneity of the C-protein alpha antigen of group B Streptococcus (1996), University of Massachusetts, Amherst 181 pp.
44. Gravekamp C., Horensky D.S., Michel J.L., and Madoff L.C. Variation in repeat number within the alpha C protein of group B Streptococcus alters antigenicity and protective epitopes. Infect Immun 64 (1996) 3576
45. Magalhaes V., Veiga-Malta I., Almeida M.R., Baptista M., Ribeiro A., Trieu-Cuot P., et al. Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect 9 (2007) 1276-1284
46. Croce A.C., Ferrigno A., Vairetti M., Bertone R., Freitas I., and Bottiroli G. Autofluorescence properties of isolated rat hepatocytes under different metabolic conditions. Photochem Photobiol Sci 3 (2004) 920-926
47. Mullins R.F., Grassi M.A., and Skeie J.M. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. Mol Vis 11 (2005) 509-517
48. Smit A.J., Hartog J.W., Voors A.A., and van Veldhuisen D.J. Advanced glycation endproducts in chronic heart failure. Ann N Y Acad Sci 1126 (2008) 225-230
49. Kling D.E., Lorenzo H.K., Trbovich A.M., Kinane T.B., Donahoe P.K., and Schnitzer J.J. MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs. Am J Physiol Lung Cell Mol Physiol 282 (2002) L370-L378
50. Motulsky H.J. Prism 4 Statistics guide-statistical analyses for laboratory and clinical researchers (2003), GraphPad Software Inc., San Diego CA